A carregar...
Direct Acting Antiviral Treatment for Patients with End-Stage Kidney Disease with Acute HCV Infection
BACKGROUND: Hepatitis C virus (HCV) infection is a public health problem. Such an infection is prevalent and aggressive in patients with end-stage kidney disease (ESKD). The efficacy and the safety of direct-acting antivirus (DAA) in patients with acute HCV and ESKD are under investigation. The aim...
Na minha lista:
| Publicado no: | Mediterr J Hematol Infect Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Università Cattolica del Sacro Cuore
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6548205/ https://ncbi.nlm.nih.gov/pubmed/31205638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2019.034 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|